使用有序β回归揭示了认知灵活性指数和正常和阿尔茨海默病病的病理衰老中的纵向认知训练特征
Daniel Alveal-Mellado1,2, Lydia Giménez-Llort1,2
1Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Barcelona, Spain.
Brain sciences
|May 25, 2024
概括
这项研究将通用线性混合模型 (GLMMs) 与有序β回归 (OBR) 结合起来,以分析莫里斯水迷宫 (MWM) 测试中的小鼠行为. 综合方法揭示了阿尔茨海默病 (AD) 模型小鼠和对照小鼠之间明显的游泳策略,突出了基因型和性别相关的差异.
科学领域:
- 神经科学是一个神经科学.
- 行为科学 行为科学
- 统计建模 统计建模
背景情况:
- 通用线性混合模型 (GLMM) 在行为研究中广泛用于分析非正常分布数据.
- 顺序β回归 (OBR) 是一种用于分析百分比数据的新型统计工具.
- 将GLMM与OBR集成,为分析连续响应数据提供了先进的功能.
研究的目的:
- 为了研究3xTg-AD小鼠 (阿尔茨海默病模型) 和C57BL/6非转基因 (NTg) 小鼠之间的行为差异.
- 在莫里斯水迷宫 (MWM) 测试中分析小鼠行为,使用集成的GLMM-OBR方法.
- 识别游泳策略和认知灵活性中的基因型和性别相关差异.
主要方法:
- 长度研究涉及3xTg-AD和NTg小鼠 (n=37) 在12个月和16个月的年龄.
- 应用了与有序β回归 (OBR) 集成的通用线性混合模型 (GLMMs).
- 在三个莫里斯水迷宫 (MWM) 范式中分析游泳策略:提示,放置任务和移除.
主要成果:
- 在所有MWM范式中观察到游泳策略的基因型差异.
- 与3xTg-AD小鼠相比,NTg小鼠的直接搜索行为比例更高.
- 循环发作与3xTg-AD动物有关,一个新的"认知灵活性指数"检测到与性别相关的差异.
结论:
- 集成的GLMMs-OBR方法为MWM测试中的老鼠行为提供了全面的见解.
- 这种方法有效地阐明了衰老和阿尔茨海默病病理学对行为的影响.
- 该研究确定了与AD和认知灵活性相关的特定行为标记,包括性别差异.
更多相关视频
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.1K
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.7K
相关概念视频
Cognitive Development During Adulthood
93
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
93
Alzheimer's Disease: Overview
465
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
465
